Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Implement Targeted Behavior Monitoring for Antipsychotic Use

Old Saybrook, Connecticut Survey Completed on 01-07-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors identified a deficiency related to the facility’s failure to implement targeted behavior monitoring for a resident who was started on an antipsychotic medication. The resident had diagnoses including catatonic disorder, major depressive disorder, anxiety disorder, delusional disorder, and unspecified psychosis, and an admission MDS BIMS score of 10/15 indicating some memory recall deficits. On 12/23/25, a psychiatric APRN documented concerns about possible undiagnosed bipolar disorder, depression, or significant trauma history and ordered a trial of Abilify 2 mg daily for delusional disorder. Facility policy dated 06/2019 required that residents receiving antipsychotic medications have specific target behaviors identified and monitored every shift, and that a behavior flow sheet be initiated any time a resident is started on an antipsychotic. Despite these requirements, review of the December 2025 eMAR showed no documentation that targeted behaviors were monitored every shift after Abilify was initiated. On 1/2/26, the psychiatric APRN documented that the resident continued to exhibit restlessness and yelling out and increased the Abilify dose to 5 mg daily for psychosis, with additional behaviors of concern including avolition and impulsiveness. Review of the January 2026 eMAR again failed to show targeted behavior monitoring every shift related to the Abilify use. In interviews, the psychiatric APRN stated that behavior monitoring should have been implemented upon initiation of Abilify, including monitoring restlessness, impulsiveness, delusions, hallucinations, and paranoia. The DON and a Regional Nurse (RN #7) also confirmed that targeted behavior monitoring should have been initiated when the Abilify order was started and that Nursing Supervisors or Nursing Administration who confirmed the order should have ensured an order for targeted behavior monitoring was put into place.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙